Exploring Attitudes Toward MDMA-Assisted Therapy in Mental Health Care
European Psychiatry June 1, 2026 A. Mechlińska, D. Swieczkowski, A. Kwaśny et al.
A cross-sectional survey of 40 healthcare professionals—psychiatrists, psychiatry residents, and psychotherapists—found cautious optimism about MDMA-assisted therapy for mental health conditions. Although 95% had no direct research involvement with MDMA, 87.5% supported further scientific studies. Most reported limited knowledge, yet 67.5% believed treatment carries risks even under medical supervision. Over 60% recognized potential positive effects, especially with psychological support, which was seen as increasing safety and efficacy. Main barriers were legal regulations (60%), lack of treatment standards (60%), and insufficient training or knowledge (60%). The authors suggest enhancing education, promoting research, and establishing clear frameworks to facilitate safe application.